RE:RE:Insider Donald John Olds Purchases 10,000 Shares (TST)
That is a good sign. The lack of insider ownership is what gives the impression that there is something people are missing. If something looks too good to be true in biotech its an avoid signal. Especially when biotech has been on a tear for the last few years. I don't think that it will have the same level of impact as the big insider sell last summer but it is a signal that the stock is under priced. I am very much anticipating the analyst reports that are coming out. I am looking for a valid explanation of how the company has managed to fly so low under the radar with such a mature pipeline.